US Stock Insider Trading | Pfizer disclosed one insider transaction on March 5

K-LinePoet · 2026-04-07T23:08:48+00:00

Pfizer executive DAMICO JENNIFER B. sold 826 shares on March 4, 2026, at a price of $26.62, with a total transaction amount of $22k. Recently, there have been multiple buy and sell transactions involving executives and directors within the company. Pfizer is a global biopharmaceutical company dedicated to the research, development, and distribution of innovative drugs and vaccines.

K-LinePoet

2026-04-07 23:08:48

Abstract generation in progress

On March 5, 2026, Pfizer (PFE) disclosed one company insider transaction. On March 4, 2026, executive DAMICO JENNIFER B. sold 826 shares.

【Recent Insider Trading】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/US Dollar	Total Amount/US Dollar
March 5, 2026	Executive	DAMICO JENNIFER B.	March 4, 2026	Sold	826	26.62	22k
March 3, 2026	Executive	DAMICO JENNIFER B.	February 27, 2026	Sold	655	27.65	18.1k
February 27, 2026	Director	BOURLA ALBERT	February 25, 2026	Bought	491.6k	33.82	16.6268 million
February 27, 2026	Executive	Fonseca Lidia、LANKLER DOUGLAS M、McDermott Michael、SAHNI PAYAL	February 25, 2026	Bought	274.6k	33.82	9.2872 million
February 27, 2026	Director	BOURLA ALBERT	February 25, 2026	Sold	467.2k	26.92	12.5781 million
February 27, 2026	Director	BOURLA ALBERT	February 25, 2026	Sold	8,303	27.09	224.9k
February 27, 2026	Executive	Fonseca Lidia、LANKLER DOUGLAS M、McDermott Michael、SAHNI PAYAL	February 25, 2026	Sold	5,018	27.09	135.9k
February 27, 2026	Executive	Fonseca Lidia、LANKLER DOUGLAS M、McDermott Michael、SAHNI PAYAL	February 25, 2026	Sold	261k	26.92	7.0258 million
February 27, 2026	Executive	McDermott Michael	February 26, 2026	Sold	3,503	27.10	94.9k
February 27, 2026	Executive	BOSHOFF CHRISTOFFEL	February 25, 2026	Sold	6,833	27.09	185.1k

【Company Profile】

Pfizer Inc. was incorporated on June 2, 1942, under the laws of the State of Delaware. The company is a research-based global biopharmaceutical company. Using science and global resources, the company brings people therapies designed to extend and significantly improve their lives, through the discovery, development, manufacture, and distribution of healthcare products (including innovative medicines and vaccines). The company operates in developed countries and emerging markets, and is committed to promoting health, preventing, treating, and curing the most dreaded diseases of this era. The company partners with healthcare providers, governments, and local communities to support and expand access to reliable and affordable healthcare services worldwide.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.